ArticleJournal of medicinal chemistry2019

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis.

Michael G Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.